Delivery Order SPE2DB22D3501-SPE2DB24FXA16
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for Pfizer COVID-19 vaccine doses to be delivered between 2024-2025, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, including 0.9 mL dosages under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price delivery order. There was no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,778.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, including a range of 6-month to 4-year doses in 0.9 mL quantities. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,138.52 firm fixed price delivery order is for the supply of Pfizer's COVID-19 vaccine for the 2023-2024 period, under the Emergency Use Authorization (EUA). The award is not set-aside, and is delivered under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,642.75 firm fixed-price delivery order is for the supply of Pfizer COVID-19 vaccine doses, including 0.9 mL doses, for the period of June 2024 to November 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,562.12 Firm Fixed Price delivery order is for the procurement of Pfizer COVID-19 vaccines (0.9 ml) to support the 2023-2024 vaccination program under the Emergency Use Authorization (EUA). The award has an ultimate completion date of February 7, 2024. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is a Firm Fixed Price Delivery Order for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 period, including an emergency use authorization (EUA) 0.9 ML product. The contract has an ultimate completion date of March 6, 2025 and was awarded on February 12, 2025. This...